Results 161 to 170 of about 9,310 (270)

Effects of Modification of the Platelet Surface on Receptors for Aggregated IgG and Ristocetin-Von Willebrand Factor [PDF]

, 1977
Sharron L. Pfueller, C. S. P. Jenkins, E. F. Lüscher   +2 more
openalex   +1 more source

Bernard-Soulier Syndrome: Case Studies From Morocco. [PDF]

Cureus
Lfaquir FZ, Mamad H, Zimi K, Benkirane S, Azlarab M.   +4 more
europepmc   +1 more source

Bortezomib in the Treatment of Acquired von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance [PDF]

, 2014
Byrd, Kenneth, Truong, Phu
core   +2 more sources

Deep molecular modeling and mechanistic insights into type 2A von Willebrand disease with von Willebrand factor A2 domain mutations. [PDF]

Res Pract Thromb Haemost
Seidizadeh O, Mollica L, Giana D, Baronciani L, Colpani P, Sicuro L, Cairo A, Peyvandi F.   +7 more
europepmc   +1 more source

Specificity of combination between mucopeptide precursors and vancomycin or ristocetin [PDF]

, 1969
H. R. Perkins
openalex   +1 more source

Recurrent thrombocytopenia with platelet clumping in a pregnant woman. [PDF]

CMAJ
Khalife R, Mahdi T, Tinmouth A.
europepmc   +1 more source

RISTOCETIN CO‐FACTOR ASSAY USING FROZEN PLATELETS [PDF]

British Journal of Haematology, 1979
openaire   +2 more sources

A new von Willebrand variant (type I, New York): increased ristocetin- induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers [PDF]

, 1986
HJ Weiss, II Sussman
openalex   +1 more source

Successful Treatment of Acquired von Willebrand Syndrome in a Rare Case of Nodal Marginal Zone Lymphoma With Rituximab Therapy: A Case Report. [PDF]

Cureus
Matsumura G, Ohno S, Hasegawa S, Shimizu R.   +3 more
europepmc   +1 more source

Trial of ZMapp for Ebola Virus Infection. [PDF]

, 2017
Fletcher, Tom, Jacob, Shevin T
core   +3 more sources